ALD is now the leading indication for LT in the US, and most centers no longer have a strict 6-month abstinence rule
Ozempic, initially approved for Type 2 diabetes in 2017, has gained popularity as a weight loss drug, Its active ingredient, semaglutide, is also present in Wegovy, a higher-dose version specifically for weight loss
Fair Use Statement The information in this article may be shared for noncommercial purposes only
THE GLP-1 hair loss timeline YOUR PRESCRIBER SKIPPED
With a better understanding of your body and the right support system, you can work through the discomfort and stay on track with your weight loss and health goals
For people with type 2 diabetes, stopping GLP-1 therapy without an alternative treatment plan can lead to deteriorating glycaemic control, which increases the risk of diabetes-related complications over time